Skip to main content

Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics

Cellular and Molecular Life Sciences volume 66, Article number: 3821 (2009) Cite this article

Abstract

Gramicidin S and polymyxins are small cationic cyclic peptides and act as potent antibiotics against Gram-negative and Gram-positive bacteria by perturbing integrity of the bacterial membranes. Screening of a natural antibiotics library with bacterial membrane vesicles identified gramicidin S as an inhibitor of cytochrome bd quinol oxidase and an alternative NADH dehydrogenase (NDH-2) and polymyxin B as an inhibitor of NDH-2 and malate: quinone oxidoreductase. Our studies showed that cationic cyclic peptide antibiotics have novel molecular targets in the membrane and interfere ligand binding on the hydrophobic surface of enzymes. Improvement of the toxicity and optimization of the structures and clinical uses are urgently needed for their effective application in combating drug-resistant bacteria.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Foster TJ (2004) The Staphylococcus aureus ‘superbug’. J Clin Invest 114:1693–1696

    CAS  PubMed  Google Scholar 

  2. Brown ED, Wright GD (2005) New targets and screening approaches in antimicrobial drug discovery. Chem Rev 105:759–774

    Article  CAS  PubMed  Google Scholar 

  3. Falagas ME, Kasiakou SK (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40:1333–1341

    Article  CAS  PubMed  Google Scholar 

  4. Evans ME, Feola DJ, Rapp RP (1999) Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram negative bacteria. Ann Pharmacother 33:960–967

    Article  CAS  PubMed  Google Scholar 

  5. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL (2006) Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 6:589–601

    Article  CAS  PubMed  Google Scholar 

  6. Michalopoulos A, Falagas ME (2008) Colistin and polymyxin B in critical care. Crit Care Clin 24:377–391

    Article  CAS  PubMed  Google Scholar 

  7. Timurkaynak F, Can F, Azap ÖK, Demirbilek M, Arslan H, Karaman SÖ (2006) In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 27:224–228

    Article  CAS  PubMed  Google Scholar 

  8. Arnold TA, Forrest G, Messmer KJ (2007) Polymyxin antibiotics for gram-negative infections. Am J Health Syst Pharm 64:819–826

    Article  CAS  PubMed  Google Scholar 

  9. Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011

    Article  CAS  PubMed  Google Scholar 

  10. Peschel A, Sahl H-G (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nature Rev Microbiol 4:529–536

    Article  CAS  Google Scholar 

  11. Bowdish DME, Davidson DJ, Hancock REW (2005) A re-evaluation of the role of host defense peptides in mammalian immunity. Curr Protein Pept Sci 6:35–51

    Article  CAS  PubMed  Google Scholar 

  12. Izumiya N, Kato T, Aoyaga H, Waki M, Kondo M (1979) Synthetic aspects of biologically active cyclic peptides: gramicidin S and tyrocidines. Halsted, New York

    Google Scholar 

  13. Waki M, Izumiya N (1990) Recent advances in the biotechnology of β-lactams and microbial bioactive peptides. In: Kleinhaug H, van Doren H (eds) Biochemistry of peptide antibiotics. de Gruyter, Berlin, pp 205–244

    Google Scholar 

  14. Xu Y, Sugár IP, Krishna NR (1995) A variable target intensity-restrained global optimization (VARTIGO) procedure for determining three-dimensional structures of polypeptides from NOESY data: application to gramicidin-S. J Biomol NMR 5:37–48

    Article  CAS  PubMed  Google Scholar 

  15. Ando S, Nishikawa H, Takiguchi H, Lee S, Sugihara G (1993) Antimicrobial specificity and hemolytic activity of cyclized basic amphiphilic β-structural model peptides and their interactions with phospholipid bilayers. Biochim Biophys Acta 1147:42–49

    Article  CAS  PubMed  Google Scholar 

  16. Kondejewski LH, Farmer SW, Wishart D, Kay CM, Hancock REW, Hodges RS (1996) Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. J Biol Chem 271:25261–25268

    Article  CAS  PubMed  Google Scholar 

  17. Otoguro K, Liu ZX, Fukuda K, Li Y, Iwai Y, Tanaka H, Ōmura S (1988) Screening for new nematocidal substances of microbial origin by a new method using the pine wood nematode. J Antibiotics 41:573–575

    CAS  Google Scholar 

  18. Mayer A, Anke H, Sterner O (1997) Omphalotin, a new cyclic peptide with potent nematicidal activity from Omphalotus olearius I. Fermentation and biological activity. Nat Product Lett 10:25–32

    Article  CAS  Google Scholar 

  19. Katsu T, Ninomiya C, Kuroko M, Kobayashi H, Hirota T, Fujita Y (1988) Action mechanism of amphipathic peptides gramicidin S and melittin on erythrocyte membrane. Biochim Biophys Acta 939:57–63

    Article  CAS  PubMed  Google Scholar 

  20. Prenner EJ, Lewis RNAH, Newman KC, Gruner SM, Kondejewski LH, Hodges RS, McElhaney RN (1997) Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane disrupting activity. Biochemistry 36:7906–7916

    Article  CAS  PubMed  Google Scholar 

  21. Jelokhani-Niaraki M, Hodges RS, Meissner JE, Hassenstein UE, Wheaton L (2008) Interaction of gramicidin S and its aromatic amino-acid analog with phospholipid membranes. Biophysical J 95:3306–3321

    Article  CAS  Google Scholar 

  22. Ashrafuzzaman Md, Andersen OS, McElhaney RN (2008) The antimicrobial peptide gramicidin S permeabilizes phospholipid bilayer membranes without forming discrete ion channels. Biochim Biophys Acta 1778:2814–2822

    Article  CAS  PubMed  Google Scholar 

  23. Salgado J, Grage SL, Kondejewski LH, Hodges RS, McElhaney RN, Ulrich AS (2001) Membrane-bound structure and alignment of the antimicrobial β-sheet peptide gramicidin S derived from angular and distance constraints by solid state 19F-NMR. J Biomol NMR 21:191–208

    Article  CAS  PubMed  Google Scholar 

  24. Wallace BA (1998) Recent advances in the high resolution structures of bacterial channels: gramicidin A. J Struct Biol 121:123–141

    Article  CAS  PubMed  Google Scholar 

  25. Kelkar DA, Chattopadhyay A (2007) The gramicidin ion channel: a model membrane protein. Biochim Biophys Acta 1768:2011–2025

    Article  CAS  PubMed  Google Scholar 

  26. Storm DR, Rosental KS, Swanson PE (1977) Polymyxin and related peptide antibiotics. Annu Rev Biochem 46:723–763

    Article  CAS  PubMed  Google Scholar 

  27. Scholar EM, Pratt WB (2000) Antibiotics that affect membrane permeability. Polymyxin B, colistin, Gramicidin A. In: Scholar EM, Pratt WB (eds) The antibacterial drugs. Oxford University Press, New York, pp 234–241

    Google Scholar 

  28. Schindler PRG, Teuber M (1975) Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob Agents Chemother 8:95–104

    CAS  PubMed  Google Scholar 

  29. Zhang L, Dhillon P, Yan H, Farmer S, Hancock REW (2000) Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrobial Agents Chemother 44:3317–3321

    Article  CAS  Google Scholar 

  30. Ui H, Ishiyama A, Sekiguchi H, Namatame M, Nishihara A, Takahashi A, Shiomi K, Otoguro K, Ōmura S (2007) Selective and potent in vitro antimalarial activities found in four microbial metabolites. J Antibiot 60:220–222

    Article  CAS  PubMed  Google Scholar 

  31. Mogi T, Ui H, Shiomi K, Ōmura S, Kita K (2008) Gramicidin S identified as a potent inhibitor for cytochrome bd-type quinol oxidase. FEBS Lett 582:2299–2302

    Article  CAS  PubMed  Google Scholar 

  32. Mogi T, Ui H, Shiomi K, Ōmura S, Miyoshi H, Kita K (2009) Antibiotics LL-Z1272 identified as novel inhibitors discriminating bacterial and mitochondrial quinol oxidases. Biochim Biophys Acta 1787:129–133

    Article  CAS  PubMed  Google Scholar 

  33. Mogi T, Ano Y, Nakatsuka T, Muroi A, Miyoshi H, Migita CT, Ui H, Shiomi K, Ōmura S, Kita K, Matsushita K (2009) Biochemical and spectroscopic properties of cyanide-insensitive quinol oxidase from Gluconobacter oxydans. J Biochem 146:263–271

    Article  CAS  PubMed  Google Scholar 

  34. Mogi T, Matsushita K, Murase Y, Kawahara K, Miyoshi H, Ui H, Shiomi K, Ōmura S, Kita K (2009) Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II). FEMS Microbiol Lett 291:157–161

    Article  CAS  PubMed  Google Scholar 

  35. Mogi T, Murase Y, Mori M, Shiomi K, Ōmura S, Paranagama MP, Kita K (2009) Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis. J Biochem 146. doi:10.1093/jb/mvp096

  36. Mogi T, Kawakami T, Arai H, Igarashi Y, Matsushita K, Mori M, Shiomi K, Ōmura S, Kita K (2009) Siccanin rediscovered as a species-selective succinate dehydrogenase inhibitor. J Biochem 146. doi:10.1093/jb/mvp085

  37. Way SS, Sallustio S, Magliozzo RS, Goldberg MB (1999) Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. J Bacteriol 181:1229–1237

    CAS  PubMed  Google Scholar 

  38. Endley S, McMurray D, Ficht TA (2001) Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J Bacteriol 183:2454–2462

    Article  CAS  PubMed  Google Scholar 

  39. Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, Mizrahi V, Gennaro ML (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 102:15629–15634

    Article  CAS  PubMed  Google Scholar 

  40. Fisher N, Bray PG, Ward SA, Biagini GA (2007) The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle. Trends Parasitol 23:305–310

    Article  CAS  PubMed  Google Scholar 

  41. Kawahara K, Mogi T, Tanaka TQ, Hata M, Miyoshi H, Kita K (2009) Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii. J Biochem 145:229–237

    Article  CAS  PubMed  Google Scholar 

  42. Kerscher SJ (2000) Diversity and origin of alternative NADH:ubiquinone oxidoreductase. Biochim Biophys Acta 1459:274–283

    Article  CAS  PubMed  Google Scholar 

  43. Mogi T, Miyoshi H (2009) Characterization of cytochrome bd plasoquinol oxidase from the cyanobacterium Synechocystis sp. PCC 6803. J Biochem 145:395–401

    Article  CAS  PubMed  Google Scholar 

  44. Yano T, Li L-S, Weinstein E, The J-S, Rubin H (2006) Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). J Biol Chem 281:11456–11463

    Article  CAS  PubMed  Google Scholar 

  45. Weinstein S, Wallace BA, Morrow JS, Veatch WR (1980) Conformation of the gramicidin A transmembrane channel: a 13C nuclear magnetic resonance study of 13C-enriched gramicidin in phosphatidylcholine vesicles. J Mol Biol 143:1–19

    Article  CAS  PubMed  Google Scholar 

  46. Fekety R (1990) Polymyxins. In: Mandell GL, Douglast RG Jr, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 323–325

    Google Scholar 

  47. Vaara M, Viljanen P (1985) Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob Agents Chemother 27:548–554

    CAS  PubMed  Google Scholar 

  48. David HL, Rastogi N (1985) Antibacterial action of colistin (polymyxin E) against Mycobacterium aurum. Antimicrob Agents Chemother 27:701–707

    CAS  PubMed  Google Scholar 

  49. McGarvey JA, Bermudez LE (2001) Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition. Infect Immun 69:7242–7249

    Article  CAS  PubMed  Google Scholar 

  50. Kasamo K (1982) Gramicidin S: a potent inhibitor of membrane-bound epidermal adenosine triphosphatase from Nicotiana tabacum L. leaves. Plant Cell Physiol 23:195–204

    CAS  Google Scholar 

  51. Zhao DY, Dhalla NS (1989) Influence of gramicidin S on cardiac membrane Ca2+/Mg2+ ATPase activities and contractile force development. Can J Physiol Pharmacol 67:546–552

    CAS  PubMed  Google Scholar 

  52. Iglesias RO, Rega AF (1987) Gramicidin S inhibition of the Ca2+-ATPase of human red blood cells. Biochim Biophys Acta 905:383–389

    Article  CAS  PubMed  Google Scholar 

  53. Takada Y, Matsuo K, Kataoka T (2008) Gramicidin A directly inhibits mammalian Na+/K+-ATPase. Mol Cell Biochem 319:99–103

    Article  CAS  PubMed  Google Scholar 

  54. Sarkar N, Langrey D, Paulus H (1977) Biological function of gramicidin: selective inhibition of RNA polymerase. Proc Natl Acad Sci USA 74:1478–1482

    Article  CAS  PubMed  Google Scholar 

  55. Kondejewski LH, Jelokhani-Niaraki M, Farmer SW, Lix B, Kay CM, Sykes BD, Hancock REW, Hodges RS (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alteration in amphipathicity. J Biol Chem 274:13181–13192

    Article  CAS  PubMed  Google Scholar 

  56. Prenner EJ, Kiricsi M, Jelokhani-Niaraki M, Lewis RNAH, Hodges RS, McElhane RN (2005) Structure-activity relationships of diastereomeric lysine ring size analogs of the antimicrobial peptide gramicidin S. Mechanism of action and discrimination between bacterial and animal cell membrane. J Biol Chem 280:2002–2011

    Article  CAS  PubMed  Google Scholar 

  57. Yamada K, Shinoda S, Oku H, Komagoe K, Katsu K, Katakai R (2006) Synthesis of low-hemolytic antimicrobial dehydropeptides based on gramicidin S. J Med Chem 49:7592–7595

    Article  CAS  PubMed  Google Scholar 

  58. Qin C, Zhong X, Bu X, Ng NLJ, Guo Z (2003) Dissociation of antimicrobial and hemeolytic activities of an amphipathic peptide antibiotics. J Med Chem 46:4830–4833

    Article  CAS  PubMed  Google Scholar 

  59. Vaara M, Fox J, Loidl G, Siikanen O, Apajalahti J, Hansen F, Frimodt-Møller N, Nagai J, Takano M, Vaara T (2008) Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob Agents Chemother 52:3229–3236

    Article  CAS  PubMed  Google Scholar 

  60. Chen C, Georgiev I, Anderson AC, Donald BR (2009) Computational structure-based redesign of enzyme activity. Proc Natl Acad Sci USA 106:3764–3769

    Article  CAS  PubMed  Google Scholar 

  61. Pattani AS, Mandawgade SD, Patravale VB (2006) Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of polymyxin B. J Nanosci Nanotechnol 6:2986–2990

    Article  CAS  PubMed  Google Scholar 

  62. Rautenbach M, Vlok NM, Stander M, Hoppe HC (2007) Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis. Biochim Biophys Acta 1768:1488–1497

    Article  CAS  PubMed  Google Scholar 

  63. Otten-Kuipers MA, Roelofsen B, Op den Kamp JAE (1995) Stage-dependent effects of analogs of gramicidin A on the growth of Plasmodium falciparum in vitro. Parasitol Res 81:26–31

    Article  CAS  PubMed  Google Scholar 

  64. Otten-Kuipers MA, Franssen FF, Nieuwenhuijs H, Overdulve JP, Roelofsen B, Op den Kamp JA (1997) Effect of tryptophan-N-formylated gramicidin on growth of Plasmodium berghei in mice. Antimicrob Agents Chemother 41:1778–1782

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank anonymous referees for their expert comments. This work was supported by grant-in-aid for Scientific Research (C) (20570124) and Creative Scientific Research (18GS0314) from the Japan Society for the Promotion of Science, and grant-in-aid for Scientific Research on Priority Areas (18073004) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Author information

Affiliations

  1. Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-0033, Japan

    Tatsushi Mogi & Kiyoshi Kita

Authors
  1. Tatsushi Mogi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiyoshi Kita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Tatsushi Mogi or Kiyoshi Kita.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mogi, T., Kita, K. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell. Mol. Life Sci. 66, 3821 (2009). https://doi.org/10.1007/s00018-009-0129-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00018-009-0129-9

Keywords

  • Bacterial membrane
  • Cationic peptide antibiotics
  • Drug target
  • Gramicidin S
  • Polymyxin
  • Respiratory enzymes